MINJUVI 200 mg powder for concentrate for solution for infusion
*Company:
Incyte Biosciences UK LtdStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 03 October 2024
File name
MINJUVI-ie-pl-clean.pdf
Reasons for updating
- Change to information for healthcare professionals
Free text change information supplied by the pharmaceutical company
Update to reconstituted solution (prior to dilution) and diluted solution (prior to dilution) based on updated stability data. Information in line with SmPC section 6.3
Updated on 03 October 2024
File name
MINJUVI-ie-spc-clean.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Update to unopened vial shelf-life from 4 years to 5 years
Update to storage conditions of reconstituted solution (prior to dilution) based upon updated stability data
Update to storage conditions of diluted solution (for infusion) based upon updated stability data
Updated on 19 July 2023
File name
ie-pl.pdf
Reasons for updating
- New PIL for new product
Updated on 19 July 2023
File name
ie-spc (1).pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 31 January 2023
File name
MINJUVI-ie-spc-ATC code.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Document format updated
Updated on 03 May 2022
File name
MINJUVI-ie-pl-ATC code.pdf
Reasons for updating
- New PIL for new product
Updated on 03 May 2022
File name
MINJUVI-ie-spc-ATC code.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)